Drug Approval | August 06, 2021
India’s gets its first bio-bank for heart failure research
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Arch Pharma Labs has filed the application
India business is growing as per projections; whereas US business will bounce back soon.
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
The company has predominantly built a portfolio into veterinary products
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website
Subscribe To Our Newsletter & Stay Updated
